Pharmacists are raising concerns about the serious threat to patient safety posed by medicine shortages. Various essential medications, including pain relievers, antibiotics, blood pressure drugs, and treatments for conditions such as epilepsy, pancreatic cancer, cystic fibrosis, diabetes, and ADHD, are currently in short supply. The utilization of Serious Shortage Protocols, which permit alternative prescriptions during shortages, is in effect for several medications, including Estradot, a hormone replacement therapy for menopausal symptoms.
Ashley Cohen, a pharmacist with nearly 35 years of experience and a National Pharmacy Association Board Member, expressed alarm over the current unprecedented levels of medicine shortages. He emphasized that the issue has escalated from a mere inconvenience to a critical patient safety concern, particularly for conditions like epilepsy where the absence of medication could lead to severe consequences.
The scarcity of medicines is attributed to soaring global prices, inadequate government funding that lags behind rising costs, and supply disruptions resulting from geopolitical events like the Iran conflict and the closure of the Strait of Hormuz, causing delays in shipping and air freight services.
Pharmacies in the UK receive fixed prices from the NHS for each dispensed medicine, and they are expected to procure the drugs at or below that set price. However, the government’s list of price concessions for April reached a record high with 210 medications exceeding the government’s price threshold.
Global drug manufacturers are reportedly prioritizing other countries over the UK due to higher payments offered elsewhere. This diversion of medication stocks, according to Mr. Cohen, is driven by economic factors, with France and Germany receiving larger medication volumes due to their higher payment rates compared to the UK.
Mr. Cohen highlighted the challenges faced in managing stocks of drugs like Creon, vital for patients with pancreatic cancer and cystic fibrosis. The consistent unavailability of Creon for almost two years has led to the rationing of this essential medication, forcing patients to seek alternatives abroad at inflated prices.
The situation has prompted concerns about the emergence of a black market, potentially endangering vulnerable patients who may resort to purchasing medications of dubious quality and effectiveness. Among those affected is Cathy Moreau, who travels to France to access Creon due to shortages in the UK, emphasizing the life-threatening consequences of not having access to essential medication.
A survey by the National Pharmacy Association revealed that 96% of pharmacies consider the shortages a significant risk to patient safety, with 83% of pharmacy staff encountering patient frustration and anger due to medication unavailability.
The National Pharmacy Association is urging the government to establish an emergency task force involving stakeholders across the supply chain to address the crisis. Additionally, there are calls for legislative changes to allow pharmacists to make necessary prescription substitutions when faced with shortages and to dispense safe alternatives.
Dr. Leyla Hannbeck, Chief Executive of the Independent Pharmacies Association, echoed concerns about the impact of medicine shortages on patients and pharmacies. She emphasized the need for urgent action to safeguard medicine supply chains and enhance patient access to critical medications.
The Department of Health and Social Care assured the public that the majority of licensed medicines in the UK are adequately supplied. The government is investing significantly in the UK’s medicine manufacturing industry to bolster supply stability and mitigate disruptions.
Efforts are underway to manage medicine shortages effectively, with collaborations between the government and industry partners to enhance UK-based medicine production. Investments in the Life Sciences Innovative Manufacturing Fund are aimed at strengthening the country’s medicine manufacturing capabilities.
The National Pharmacy Association is advocating for immediate government intervention through the establishment of a task force involving key stakeholders to combat the ongoing medicine shortages. The Royal College of GPs supports empowering pharmacists to make prescription changes when necessary and dispense safe alternatives during shortages.